These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 32950313)

  • 21. Results of Resection for Recurrent or Residual Retroperitoneal Sarcoma After Failed Primary Treatment.
    Hamilton TD; Cannell AJ; Kim M; Catton CN; Blackstein ME; Dickson BC; Gladdy RA; Swallow CJ
    Ann Surg Oncol; 2017 Jan; 24(1):211-218. PubMed ID: 27554502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soft Tissue Sarcomas of the Extremities: Surgical Margins Can Be Close as Long as the Resected Tumor Has No Ink on It.
    Harati K; Goertz O; Pieper A; Daigeler A; Joneidi-Jafari H; Niggemann H; Stricker I; Lehnhardt M
    Oncologist; 2017 Nov; 22(11):1400-1410. PubMed ID: 28739867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.
    Singer S; Antonescu CR; Riedel E; Brennan MF
    Ann Surg; 2003 Sep; 238(3):358-70; discussion 370-1. PubMed ID: 14501502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma.
    Nathenson MJ; Barysauskas CM; Nathenson RA; Regine WF; Hanna N; Sausville E
    World J Surg Oncol; 2018 Oct; 16(1):203. PubMed ID: 30309356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.
    Keung EZ; Chiang YJ; Cormier JN; Torres KE; Hunt KK; Feig BW; Roland CL
    Cancer; 2018 Dec; 124(23):4495-4503. PubMed ID: 30317543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retroperitoneal sarcoma: 25 years of experience with aggressive surgical treatment at the Institute of Oncology, Ljubljana.
    Erzen D; Sencar M; Novak J
    J Surg Oncol; 2005 Jul; 91(1):1-9. PubMed ID: 15999353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of prognostic factors for liposarcoma].
    Zhang Q; Li JM; Liu JL; Wei YZ
    Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):943-948. PubMed ID: 31874553
    [No Abstract]   [Full Text] [Related]  

  • 28. Management of locoregional recurrence after radical resection of a primary nonmetastatic retroperitoneal soft tissue sarcoma: The Gustave Roussy experience.
    Honoré C; Faron M; Mir O; Haddag-Miliani L; Dumont S; Terrier P; LePéchoux C; Botticella A; Adam J; Le Cesne A
    J Surg Oncol; 2018 Dec; 118(8):1318-1325. PubMed ID: 30399202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aggressive and frequent resection of recurrences in retroperitoneal sarcoma contributes to long-term survival.
    Komori K; Tsukushi S; Yoshida M; Kinoshita T; Oshiro T; Ouch A; Ito S; Abe T; Misawa K; Ito Y; Natsume S; Higaki E; Okuno M; Hosoi T; Shoji K; Kunitomo A; Oki S; Suenaga Y; Maeda S; Nagao T; Dei H; Numata Y; Aritake T; Tawada K; Shimizu Y
    Langenbecks Arch Surg; 2021 Aug; 406(5):1635-1642. PubMed ID: 33449172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma.
    Tan MC; Brennan MF; Kuk D; Agaram NP; Antonescu CR; Qin LX; Moraco N; Crago AM; Singer S
    Ann Surg; 2016 Mar; 263(3):593-600. PubMed ID: 25915910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined management of retroperitoneal sarcoma with dose intensification radiotherapy and resection: long-term results of a prospective trial.
    Smith MJ; Ridgway PF; Catton CN; Cannell AJ; O'Sullivan B; Mikula LA; Jones JJ; Swallow CJ
    Radiother Oncol; 2014 Jan; 110(1):165-71. PubMed ID: 24411227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncology outcomes in Retroperitoneal sarcomas: Prognostic factors in a Retrospective Cohort study.
    Garcia-Ortega DY; Villa-Zepeda O; Martinez-Said H; Cuellar-Hübbe M; Luna-Ortiz K
    Int J Surg; 2016 Aug; 32():45-9. PubMed ID: 27268726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor biology remains the main determinant of prognosis in retroperitoneal sarcomas: a 14-year single-center experience.
    Ng DWJ; Tan GHC; Chia CS; Chee SK; Quek R; Farid M; Teo MCC
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e458-e465. PubMed ID: 28371454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience with surgical treatment of retroperitoneal soft tissue sarcomas at a university hospital in Thailand.
    Sriussadaporn S; Sriussadaporn S; Pak-art R; Kritayakirana K; Prichayudh S; Samorn P
    J Med Assoc Thai; 2014 Jun; 97(6):598-614. PubMed ID: 25137877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features of multiply recurrent retroperitoneal liposarcoma: A single-center experience.
    Masaki N; Onozawa M; Inoue T; Kurobe M; Kawai K; Miyazaki J
    Asian J Surg; 2021 Jan; 44(1):380-385. PubMed ID: 33191070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrence patterns after resection of retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative.
    Chouliaras K; Senehi R; Ethun CG; Poultsides G; Tran T; Grignol V; Gamblin TC; Roggin KK; Tseng J; Fields RC; Weber SM; Russell GB; Levine EA; Cardona K; Votanopoulos K
    J Surg Oncol; 2019 Sep; 120(3):340-347. PubMed ID: 31246290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Retroperitoneal sarcomas: diagnostic and therapy].
    Gockel I; Oberholzer K; Gönner U; Mantai S; Junginger T
    Zentralbl Chir; 2006 Jun; 131(3):223-9. PubMed ID: 16739063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent retroperitoneal sarcoma: impact of biology and therapy on outcomes.
    Grobmyer SR; Wilson JP; Apel B; Knapik J; Bell WC; Kim T; Bland KI; Copeland EM; Hochwald SN; Heslin MJ
    J Am Coll Surg; 2010 May; 210(5):602-8, 608-10. PubMed ID: 20421013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcomes in treatment of retroperitoneal sarcomas: A 15 year single-institution evaluation of prognostic features.
    Abdelfatah E; Guzzetta AA; Nagarajan N; Wolfgang CL; Pawlik TM; Choti MA; Schulick R; Montgomery EA; Meyer C; Thornton K; Herman J; Terezakis S; Frassica D; Ahuja N
    J Surg Oncol; 2016 Jul; 114(1):56-64. PubMed ID: 27076350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.
    Keung EZ; Hornick JL; Bertagnolli MM; Baldini EH; Raut CP
    J Am Coll Surg; 2014 Feb; 218(2):206-17. PubMed ID: 24315890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.